Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ABEO Historical Stock Prices |
| Preferred Stock Newsletter |
| ABEO Options Chain |
| Stock Message Boards |
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on September 19, 2022, ABEO opened at $3.90, traded as high as $3.95 and as low as $3.77, and closed at $3.86. Trading volume was a total of 71.20K shares. On September 20, 2022, ABEO opened at $3.78, traded as high as $3.85 and as low as $3.62, and closed at $3.72. Trading volume was a total of 92.60K shares. On September 21, 2022, ABEO opened at $3.71, traded as high as $3.79 and as low as $3.53, and closed at $3.58. Trading volume was a total of 92.40K shares. On September 22, 2022, ABEO opened at $3.58, traded as high as $3.58 and as low as $3.20, and closed at $3.25. Trading volume was a total of 119.60K shares. On September 23, 2022, ABEO opened at $3.23, traded as high as $3.29 and as low as $2.96, and closed at $3.03. Trading volume was a total of 69.40K shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 09/26/2012 | |
| End date: | 09/23/2022 | |
| Start price/share: | $11.25 | |
| End price/share: | $3.03 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -73.07% | |
| Average Annual Total Return: | -12.30% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $2,692.48 | |
| Years: | 10.00 | |
 | |||||
| ABEO Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 09/19/2022 | $3.90 | $3.95 | $3.77 | $3.86 | 71.20K |
| 09/20/2022 | $3.78 | $3.85 | $3.62 | $3.72 | 92.60K |
| 09/21/2022 | $3.71 | $3.79 | $3.53 | $3.58 | 92.40K |
| 09/22/2022 | $3.58 | $3.58 | $3.20 | $3.25 | 119.60K |
| 09/23/2022 | $3.23 | $3.29 | $2.96 | $3.03 | 69.40K |
|
| About Abeona Therapeutics |
| Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL™ clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM™ capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs. |
| ABEO Historical Closing Prices | |
| Date | Close |
| 09/19/2022 | $3.86 |
| 09/20/2022 | $3.72 |
| 09/21/2022 | $3.58 |
| 09/22/2022 | $3.25 |
| 09/23/2022 | $3.03 |
| Healthcare Historical Prices |
| ABEO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABIO Historical Stock Prices Also explore: ABEO shares outstanding history
|
Free ABEO Email Alerts:
